References
- PritzkerLBNguyenTAMoscarelloMAThe developmental expression and activity of peptidylarginine deiminase in the mouseNeurosci Lett1999266316116410465698
- AritaKHashimotoHShimizuTNakashimaKYamadaMSatoMStructural basis for Ca(2+)-induced activation of human PAD4Nat Struct Mol Biol200411877778315247907
- ChavanasSMéchinMCNachatRPeptidylarginine deiminases and deimination in biology and pathology: relevance to skin homeostasisJ Dermatol Sci2006442637216973334
- MohananSCherringtonBDHoribataSMcElweeJLThompsonPRCoonrodSAPotential role of peptidylarginine deiminase enzymes and protein citrullination in cancer pathogenesisBiochem Res Int2012201289534323019525
- MéchinMCCoudaneFAdoueVDeimination is regulated at multiple levels including auto-deimination of peptidylarginine deiminasesCell Mol Life Sci20106791491150320111885
- LewisHDNachtMiPAD or PADi-‘tablets’ with therapeutic disease potential?Curr Opin Chem Biol20163316917827372273
- McElweeJLMohananSGriffithOLIdentification of PADI2 as a potential breast cancer biomarker and therapeutic targetBMC Cancer20121250023110523
- McElweeJLMohananSHoribataSPAD2 overexpression in transgenic mice promotes spontaneous skin neoplasiaCancer Res201474216306631725213324
- TandaySTargeting PADI2 could stop the progression of myelomaLancet Oncol2016178e325
- WangHXuBZhangXZhengYZhaoYChangXPADI2 gene confers susceptibility to breast cancer and plays tumorigenic role via ACSL4, BINC3 And CA9 signalingCancer Cell Int2016166127478411
- CantarinoNMusulenEValeroVDownregulation of the deiminase PADI2 is an early event in colorectal carcinogenesis and indicates poor prognosisMol Cancer Res201614984184827280713
- KooCLKokLFLeeMYScoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray studyJ Transl Med200972519366452
- BriggsDJSkeelesJKAn enzyme-linked immunosorbent assay for detecting antibodies to Pasteurella multocida in chickensAvian Dis19842812082156721793
- GalesDClarkCManneUSamuelTThe chemokine CXCL8 in carcinogenesis and drug responseISRN Oncol2013201385915424224100
- LiuQLiATianYThe CXCL8-CXCR1/2 pathways in cancerCytokine Growth Factor Rev201631617127578214
- ChengWLWangCSHuangYHTsaiMMLiangYLinKHOver-expression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancerAnn Oncol201122102267227621343381
- WangJHuWWangKRepertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracilInt J Oncol20164841341135226847910
- YangZSunBZhaoXErythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosisInt J Clin Exp Pathol2015844033404326097591
- LombarderoMKovacsKScheithauerBWErythropoietin: a hormone with multiple functionsPathobiology2011781415321474975
- FarrellFLeeAThe erythropoietin receptor and its expression in tumor cells and other tissuesOncologist20049suppl 5183015591419
- MoreiraLBeirãoJMBeirãoIPinho e CostaPOligomeric TTR V30M aggregates compromise cell viability, erythropoietin gene expression and promoter activity in the human hepatoma cell line Hep3BAmyloid2015222939926088020
- LiTLiuZJiangKRuanQAngiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activationCancer Lett2013337227628423643942
- EhnertSFreudeTEicherCDarbepoetin inhibits proliferation of hepatic cancer cells in the presence of TGF-βArch Toxicol2014881899623877120
- ZhengYZhaoGXuBPADI4 has genetic susceptibility to gastric carcinoma and upregulates CXCR2, KRT14 and TNF-α expression levelsOncotarget2016738621596217627556695